HighTower Advisors
TTHI

HighTower Advisors’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

HighTower Advisors’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,900
Closed -$81K – 1864
2015
Q1 		$81K Sell
11,900
-2,500
-17% -$17.3K ﹤0.01% 1511
2014
Q4 		$97K Sell
14,400
-3,500
-20% -$22.6K ﹤0.01% 1476
2014
Q3 		$123K Hold
17,900
– – ﹤0.01% 1420
2014
Q2 		$123K Buy
17,900
+400
+2% +$2.32K ﹤0.01% 1461
2014
Q1 		$140K Sell
17,500
-8,000
-31% -$55.1K ﹤0.01% 1357
2013
Q4 		$144K Buy
+25,500
New +$131K ﹤0.01% 1350

Other funds holding TTHI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

HighTower Advisors's TTHI Position: Q2 2015 in Review

HighTower Advisors sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q2 2015, closing a stake of 11,900 shares — an estimated $81K sold.

HighTower Advisors first reported a position in TTHI in Q4 2013 and held it in 6 quarters. The position peaked at $144K in Q4 2013. 30 funds tracked by Wall St. Rank hold TTHI as of Q2 2015.

  • HighTower Advisors reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q2 2015 after selling out during the quarter.
  • HighTower Advisors sold 11,900 TRANSITION THERAPEUTICS INC (CANADA) shares in Q2 2015, an estimated $81K.
  • HighTower Advisors first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q4 2013 and held it in 6 quarters.
  • HighTower Advisors's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $144K in Q4 2013.
  • 30 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q2 2015.

Based on HighTower Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.